Gall Matthew bought TNGX
May 1, 2026 · Form 4 insider transaction
Gall Matthew bought 40,000 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderGall Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest over a three-year period at a rate of (i) 13,200 RSUs on or about May 10, 2027, (ii) 13,200 RSUs on or about May 10, 2028 and (iii) 13,600 RSUs on or about May 9, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.